8-K: Sabra Reports Strong Q4 2025, Boosts 2026 Outlook

Sentiment:

Quarterly Report


Sabra Health Care REIT, Inc. announced robust fourth-quarter 2025 results and introduced optimistic 2026 guidance, driven by strong investment activity and operational improvements across its portfolio.

Capital raiseIssued 2.3 million shares in settlement of outstanding forward sale agreements at a weighted average price of $17.49 per share, net of commissions, resulting in net proceeds of $40.0 million during Q4 2025.As of December 31, 2025, 17.4 million shares remained outstanding under forward sale agreements at a weighted average price of $18.60 per share, net of commissions.Expects to fund awarded investments with available liquidity, including proceeds from outstanding forward sales agreements under its current and prior at-the-market equity offering programs (ATM programs).Had $482.9 million of availability under its current ATM program as of December 31, 2025.

Summary

  • Net Income for the fourth quarter of 2025 was $0.11 per diluted common share.
  • Normalized FFO for Q4 2025 was $0.36 per diluted common share, and Normalized AFFO was $0.38 per diluted common share.
  • Same property managed senior housing Cash NOI increased 12.6% year-over-year for Q4 2025, with a 15.0% average increase for the full year 2025.
  • Sabra acquired four managed senior housing properties for $150.5 million in Q4 2025, with an estimated initial cash yield of 7.0%.
  • Total investments closed in 2025 amounted to approximately $450 million, with an estimated average initial cash yield of 7.5% on property acquisitions.
  • An additional $240 million of primarily managed senior housing and some skilled nursing investments have been awarded, with an estimated initial cash yield of approximately 8.0%, expected to close in Q1 and early Q2 2026.
  • Seven skilled nursing facilities were disposed of for gross proceeds of $51.0 million during Q4 2025.
  • Sabra issued 2.3 million shares in settlement of outstanding forward sale agreements, generating net proceeds of $40.0 million in Q4 2025.
  • Net Debt to Adjusted EBITDA stood at 5.00x as of December 31, 2025.
  • A quarterly cash dividend of $0.30 per share of common stock was declared on February 2, 2026, payable on February 27, 2026.
  • The company initiated 2026 guidance with Normalized FFO ranging from $1.49 to $1.53 and Normalized AFFO ranging from $1.55 to $1.59 per diluted common share, implying 4.9% and 5.4% year-over-year growth at the midpoint, respectively.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a solid performance with clear strategic execution and positive forward guidance, though some Q4 GAAP metrics show a decline. The robust investment pipeline and operational improvements are strong indicators.

Positives

  • Same property managed senior housing Cash NOI showed strong year-over-year growth of 12.6% in Q4 2025 and an average of 15.0% for the full year 2025.
  • Significant investment activity in 2025, totaling approximately $450 million, with an attractive average initial cash yield of 7.5%.
  • A robust investment pipeline for 2026 includes $240 million of awarded investments with an estimated initial cash yield of 8.0%.
  • Positive operational trends are observed across all segments, including increasing managed senior housing occupancy and margins, stable triple-net senior housing with strong rent coverage, and an upward trajectory in skilled nursing portfolio occupancy and rent coverage.
  • The 2026 Normalized FFO and Normalized AFFO guidance implies healthy year-over-year growth of 4.9% and 5.4% at the midpoint, respectively.
  • Sabra maintained ample liquidity of approximately $1.2 billion as of December 31, 2025.
  • A significant portion of borrowings (98%) is unsecured, providing enhanced balance sheet flexibility.
  • The company has a favorable debt maturity profile with no material debt maturities until 2028.
  • The weighted average effective interest rate on permanent debt is a competitive 3.92%.

Negatives

  • Net Income per diluted common share decreased to $0.11 in Q4 2025 from $0.19 in Q4 2024.
  • A net loss on sales of real estate of $9.063 million was recognized in Q4 2025, compared to a gain of $6.064 million in Q4 2024.
  • Rental and related revenues decreased from $96,068 million in Q4 2024 to $92,917 million in Q4 2025.
  • An impairment of real estate charge of $648 thousand was recorded in Q4 2025.

Risks

  • The ability to reach definitive agreements for awarded investments and to close such acquisitions on expected terms or at all.
  • Increases in market interest rates and inflation.
  • The impact of pandemics or epidemics, and related effects on tenants, borrowers, and senior housing managed communities.
  • Operational risks associated with senior housing managed communities.
  • Increased labor costs and labor shortages.
  • Competitive conditions within the industry.
  • The loss of key management personnel.
  • Uninsured or underinsured losses affecting properties.
  • Potential impairment charges and adjustments related to the accounting of assets.
  • Risks associated with investments in unconsolidated joint ventures.
  • Catastrophic weather and other natural or man-made disasters, the effects of climate change on properties, and a failure to implement sustainable and energy-efficient measures.
  • Increased operating costs and competition for tenants, borrowers, and senior housing managed communities.
  • Increased healthcare regulation and enforcement.
  • Tenants' dependency on reimbursement from governmental and other third-party payor programs.
  • The effect of tenants, operators, or borrowers declaring bankruptcy or becoming insolvent.
  • The ability to find replacement tenants and the impact of unforeseen costs in acquiring new properties.
  • The impact of litigation and rising insurance costs on the business of tenants.
  • The impact of required regulatory approvals of transfers of healthcare properties.
  • Environmental compliance costs and liabilities associated with owned real estate properties.
  • Tenants', borrowers', or operators' failure to adhere to applicable privacy and data security laws, or a material breach of information technology.
  • Concentration in the healthcare property sector, particularly in skilled nursing/transitional care facilities and senior housing communities, which makes profitability more vulnerable to a downturn in a specific sector.
  • The significant amount of and the ability to service indebtedness.
  • Covenants in debt agreements that may restrict the ability to pay dividends, make investments, incur additional indebtedness, and refinance indebtedness on favorable terms.
  • Adverse changes in credit ratings.
  • The ability to make dividend distributions at expected levels.
  • The ability to raise capital through equity and debt financings.
  • Changes and uncertainty in macroeconomic conditions and disruptions in the financial markets.
  • Risks associated with property ownership outside the U.S., including currency fluctuations.
  • The relatively illiquid nature of real estate investments.
  • The ability to maintain status as a real estate investment trust (REIT) under federal tax laws.
  • Compliance with REIT requirements and certain tax and tax regulatory matters related to REIT status.
  • Changes in tax laws and regulations affecting REITs.
  • The ownership limits and takeover defenses in governing documents and under Maryland law, which may restrict change of control or business combination opportunities.
  • Exclusive forum provisions in bylaws.

Future Outlook

Sabra anticipates continued positive operational trends and expects to exceed 2025's investment total in 2026, focusing strategically on growing its managed senior housing portfolio and making additional skilled nursing investments. The company projects low-single-digit Cash NOI growth for its triple-net portfolio and low to mid-teens growth for its same-store Senior Housing Managed portfolio in 2026.

Management Comments

  • "We are pleased to introduce 2026 Normalized FFO and Normalized AFFO guidance at 4.9% and 5.4% year over year growth at the midpoint, respectively, building on a successful 2025." Rick Matros, CEO and Chair.
  • "Our investment pipeline remains robust, and 2026 has gotten off to a strong start with $240 million of awarded investments, much of which should close in Q1 and early Q2." Rick Matros, CEO and Chair.
  • "Sabra's operational results continue to trend positively, as we have seen over the last year plus. Managed senior housing occupancy and margins continue to increase, triple-net senior housing remains stable with strong rent coverage and occupancy, and our skilled nursing portfolio's upward trajectory in occupancy and rent coverage continues." Rick Matros, CEO and Chair.
  • "We are excited about the prospects for 2026." Rick Matros, CEO and Chair.
  • "We deliver long-term value to our shareholders by deliberately executing on our strategy and investing in our tenants success by providing flexible capital solutions that keep them at the forefront of healthcare delivery." Darrin Smith, Chief Investment Officer.
  • "Our strong balance sheet and ready access to capital allows us to thoughtfully finance investment opportunities and drive value for our shareholders." Michael Costa, Chief Financial Officer.

Industry Context

StockSavvy.ai notes that Sabra's strategic focus on managed senior housing and skilled nursing aligns well with broader industry trends, particularly the significant growth expected in the 85-or-older population (projected 4% annually through 2040) and the ongoing scarcity of new supply in these healthcare real estate sectors. The reported positive operational trends and robust investment pipeline suggest Sabra is effectively capitalizing on these favorable demographic and market dynamics within the competitive healthcare REIT landscape.

Comparison to Industry Standards

  • Sabra's Net Debt to Adjusted EBITDA of 5.00x falls within the investment-grade peer range of 0.40x 5.28x, indicating a sound leverage position.
  • The company's Interest Coverage Ratio of 4.72x is competitive, sitting within the peer range of 4.30x 9.22x.
  • Sabra's Total Debt/Asset Value of 37% is comparable to industry standards, within the peer range of 18% 39%.
  • With Secured Debt/Asset Value at 1%, Sabra demonstrates a low reliance on secured debt, aligning with the peer range of 0% 7%.
  • Sabra's Skilled Nursing/Transitional Care (SNF) EBITDARM Coverage of 2.38x compares favorably to peers such as LTC (1.93x), OHI (2.15x), and AHR (2.16x), though slightly below CTRE (3.16x) and NHI (3.17x), indicating solid operator performance.
  • The Senior Housing EBITDARM Coverage of 1.52x is competitive against peers like VTR (1.30x), LTC (1.36x), AHR (1.38x), WELL (1.40x), and NHI (1.53x).
  • Sabra's portfolio composition, with 47.8% in Skilled Nursing/Transitional Care and 34.4% in Senior Housing (Managed and Leased), reflects a diversified healthcare real estate strategy, with its SNF concentration (48%) comparable to NHI (29%), LTC (51%), OHI (60%), AHR (64%), and CTRE (79%).

Stakeholder Impact

  • Shareholders: Positive impact due to strong operational performance, robust investment pipeline, healthy dividend declaration ($0.30 per share), and positive 2026 guidance for FFO/AFFO growth. Potential for dilution from ATM program.
  • Tenants/Operators: Continued support through flexible capital solutions and strategic partnerships, aiming for their success in healthcare delivery.
  • Employees: Implied stability and growth given the positive company outlook and strategic initiatives.
  • Customers (Residents/Patients): Enhanced quality of care through Sabra's commitment to supporting skilled operators and sustainability initiatives.

Next Steps

  • Closing of two additional managed senior housing properties for $27.0 million (subsequent to quarter end).
  • Expected closing of $240 million of awarded investments (primarily managed senior housing and some skilled nursing) in Q1 and early Q2 2026.
  • A conference call and webcast to discuss the 2025 fourth quarter results will be held on Friday, February 13, 2026, at 11:00 am Pacific Time.
  • Expects to exceed 2025's investment total in 2026.
  • Anticipates making skilled nursing investments in addition to growing the managed senior housing portfolio in 2026.

Key Dates

DateDescription
December 31, 2025End of the fourth quarter and fiscal year for reported results.
February 2, 2026Sabra's Board of Directors declared a quarterly cash dividend of $0.30 per share.
February 12, 2026Date of the earnings release and introduction of 2026 guidance.
February 13, 2026Record date for common stockholders to receive the declared dividend; conference call and webcast to discuss Q4 2025 results.
February 27, 2026Payment date for the quarterly cash dividend.
Q1 and early Q2 2026Expected closing period for $240 million of awarded investments.
2040Projected period for 4% annual growth in the 80-or-older population.

Recommendation

hold

The company demonstrates solid operational performance, a robust investment pipeline, and positive 2026 guidance, indicating continued growth. However, the Q4 GAAP net income decline and ongoing capital raise activities (ATM program) suggest a balanced outlook. The stock appears to be performing as expected within its sector, warranting a hold recommendation for investors seeking stable, income-generating assets with growth potential, but without immediate catalysts for significant outperformance.

Keywords

Healthcare REIT, Senior Housing, Skilled Nursing, Real Estate Investment, Q4 Earnings, 2026 Guidance, Property Acquisitions, Asset Dispositions, REIT, SBRA, Healthcare Properties, Financial Performance, Investment Pipeline, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.